Rapamycin-induced autophagy activity promotes bone fracture healing in rats Corrigendum in /10.3892/etm.2021.9749

Yang,Ge; Duan,Xunhong; Lin,Dasheng; Li,Ten; Luo,Deqing; Wang,Lei; Lian,Kejian

doi:10.3892/etm.2015.2660

Rapamycin-induced autophagy activity promotes bone fracture healing in rats

Corrigendum in: /10.3892/etm.2021.9749

Authors:
- Ge Yang
- Xunhong Duan
- Dasheng Lin
- Ten Li
- Deqing Luo
- Lei Wang
- Kejian Lian
View Affiliations

Affiliations: Department of Orthopedic Surgery, The Affiliated Southeast Hospital of Xiamen University, Orthopedic Center of People's Liberation Army, Zhangzhou, Fujian 363000, P.R. China
Published online on: July 27, 2015 https://doi.org/10.3892/etm.2015.2660
Pages: 1327-1333
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Autophagy is a crucial mediating process for normal bone cell function and metabolism in physiology or pathology. Rapamycin has been demonstrated to induce the autophagy pathway by inhibiting the mammalian target of rapamycin (mTOR) pathway. However, the contribution of autophagy in orthopedic diseases is rarely reported. The aim of the present study was to evaluate the capacity of pharmacologically induced autophagy to modify disease function in a rat model of bone fracture. A femur fracture model was established via surgery in adult male Sprague‑Dawley rats. Rapamycin (n=63 rats) or dimethyl sulfoxide (DMSO) vehicle control (n=63 rats) was administered intraperitoneally for 2, 4 and 6 weeks, and 21 randomly selected rats were sacrificed in each group at each time point. X‑ray micro‑computed tomography and hematoxylin and eosin staining were used to evaluate the extent of fracture healing in each group. The effects of rapamycin on autophagy, mTOR signaling and the expression levels of vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (PCNA) were analyzed using immunohistochemistry, immunofluorescence staining and western blot analysis. Rapamycin affected the mTOR signaling pathway in rats following fracture, as indicated by the inhibition of the phosphorylation of ribosomal protein S6, a target of mTOR, and activation of microtubule‑associated protein 2 light chain 3, a key marker of autophagy. Histomorphometry and image examination indicated that the number of osteoblasts in each section was significantly (P<0.01) increased in the rapamycin group compared with the control group, and this was associated with a significant (P<0.05) increase in mineralized callus fraction. Furthermore, rapamycin treatment increased the expression levels of VEGF and PCNA in the rat callus tissue. These results suggest that rapamycin may serve a beneficial function in fracture healing, and that the underlying mechanism may involve the activation of autophagy.

View Figures

View References

1	Einhorn T: Enhancement of fracture-healing. J Bone Joint Surg Am. 77:940–956. 1995.PubMed/NCBI
2	O'Neill KR, Stutz CM, Mignemi NA, et al: Micro-computed tomography assessment of the progression of fracture healing in mice. Bone. 50:1357–1367. 2012. View Article : Google Scholar : PubMed/NCBI
3	Mizushima N, Levine B, Cuervo AM and Klionsky DJ: Autophagy fights disease through cellular self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
4	Levine B and Kroemer G: Autophagy in the pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
5	Mathew R, Karp CM, Beaudoin B, et al: Autophagy suppresses tumorigenesis through elimination of p62. Cell. 137:1062–1075. 2009. View Article : Google Scholar : PubMed/NCBI
6	Hara T, Nakamura K, Matsui M, et al: Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 441:885–889. 2006. View Article : Google Scholar : PubMed/NCBI
7	Komatsu M, Waguri S, Ueno T, et al: Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol. 169:425–434. 2005. View Article : Google Scholar : PubMed/NCBI
8	Shibata M, Lu T, Furuya T, et al: Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1. J Biol Chem. 281:14474–14485. 2006. View Article : Google Scholar : PubMed/NCBI
9	Su JC, Tseng PH, Hsu CY, et al: RFX1-dependent activation of SHP-1 induces autophagy by a novel obatoclax derivative in hepatocellular carcinoma cells. Oncotarget. 5:4909–4919. 2014.PubMed/NCBI
10	Wullschleger S, Loewith R and Hall MN: TOR signaling in growth and metabolism. Cell. 124:471–484. 2006. View Article : Google Scholar : PubMed/NCBI
11	Dann SG, Selvaraj A and Thomas G: mTOR Complex1-S6K1 signaling: At the crossroads of obesity, diabetes and cancer. Trends Mol Med. 13:252–259. 2007. View Article : Google Scholar : PubMed/NCBI
12	Shigemitsu K, Tsujishita Y, Hara K, Nanahoshi M, Avruch J and Yonezawa K: Regulation of translational effectors by amino acid and mammalian target of rapamycin signaling pathways. Possible involvement of autophagy in cultured hepatoma cells. J Biol Chem. 274:1058–1065. 1999. View Article : Google Scholar : PubMed/NCBI
13	Sabers CJ, Martin MM, Brunn GJ, et al: Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J Biol Chem. 270:815–822. 1995. View Article : Google Scholar : PubMed/NCBI
14	Sarkar S and Rubinsztein DC: Huntington's disease: Degradation of mutant huntingtin by autophagy. FEBS J. 275:4263–4270. 2008. View Article : Google Scholar : PubMed/NCBI
15	Harrison DE, Strong R, Sharp ZD, et al: Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 460:392–395. 2009.PubMed/NCBI
16	Pan T, Rawal P, Wu Y, Xie W, Jankovic J and Le W: Rapamycin protects against rotenone-induced apoptosis through autophagy induction. Neuroscience. 164:541–551. 2009. View Article : Google Scholar : PubMed/NCBI
17	Spilman P, Podlutskaya N, Hart MJ, et al: Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One. 5:e99792010. View Article : Google Scholar : PubMed/NCBI
18	Inuzuka Y, Okuda J, Kawashima T, et al: Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice. Circulation. 120:1695–1703. 2009. View Article : Google Scholar : PubMed/NCBI
19	Holstein JH, Menger MD, Culemann U, Meier C and Pohlemann T: Development of a locking femur nail for mice. J Biomech. 40:215–219. 2007. View Article : Google Scholar : PubMed/NCBI
20	Müller ME, Nazarian S, Koch P and Schatzker J: The Comprehensive Classification of Fractures of Long Bones. 1st edition. Springer; New York, NY: 1994
21	Ekim B, Magnuson B, AcostaJaquez HA, Keller JA, Feener EP and Fingar DC: mTOR kinase domain phosphorylation promotes mTORC1 signaling, cell growth and cell cycle progression. Mol Cell Biol. 31:2787–2801. 2011. View Article : Google Scholar : PubMed/NCBI
22	Moscat J and Diaz-Meco MT: p62 at the crossroads of autophagy, apoptosis and cancer. Cell. 137:1001–1004. 2009. View Article : Google Scholar : PubMed/NCBI
23	Lin NY, Stefanica A and Distler JH: Autophagy: A key pathway of TNF-induced inflammatory bone loss. Autophagy. 9:1253–1255. 2013. View Article : Google Scholar : PubMed/NCBI
24	Zhang L, Guo YF, Liu YZ, et al: Pathway-based genome-wide association analysis identified the importance of regulation-of-autophagy pathway for ultradistal radius BMD. J Bone Miner Res. 25:1572–1580. 2010. View Article : Google Scholar : PubMed/NCBI
25	Zoncu R, Efeyan A and Sabatini DM: mTOR: From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 12:21–35. 2011. View Article : Google Scholar : PubMed/NCBI
26	Guertin DA and Sabatini DM: The pharmacology of mTOR inhibition. Sci Signal. 2:pe242009.PubMed/NCBI
27	Yu X, Guo Y, Kang Q and Luo C: Effects and mechanisms of mechanical stress on secondary fracture healing. Front Biosci (Landmark Ed). 18:1344–1348. 2013. View Article : Google Scholar : PubMed/NCBI
28	Keramaris NC, Calori GM, Nikolaou VS, Schemitsch EH and Giannoudis PV: Fracture vascularity and bone healing: A systematic review of the role of VEGF. Injury. 39 (Suppl 2):S45–S57. 2008. View Article : Google Scholar : PubMed/NCBI
29	Morrow PW, Tung HY and Hemmings HC Jr: Rapamycin causes activation of protein phosphatase-2A1 and nuclear translocation of PCNA in CD4⁺ T cells. Biochem Biophys Res Commun. 323:645–651. 2004. View Article : Google Scholar : PubMed/NCBI
30	Kobayashi S, Kishimoto T, Kamata S, Otsuka M, Miyazaki M and Ishikura H: Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis. Cancer Sci. 98:726–733. 2007. View Article : Google Scholar : PubMed/NCBI
31	Kawahara T, Asthana S and Kneteman NM: m-TOR inhibitors: What role in liver transplantation? J Hepatol. 55:1441–1451. 2011. View Article : Google Scholar : PubMed/NCBI
32	Cirstea D, Hideshima T, Rodig S, et al: Dual inhibition of Akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple myeloma. Mol Cancer Ther. 9:963–975. 2010. View Article : Google Scholar : PubMed/NCBI
33	Caramés B, Taniguchi N, Otsuki S, Blanco FJ and Lotz M: Autophagy is a protective mechanism in normal cartilage and its aging-related loss is linked with cell death and osteoarthritis. Arthritis Rheum. 62:791–801. 2010. View Article : Google Scholar : PubMed/NCBI
34	Wong E and Cuervo AM: Autophagy gone awry in neurodegenerative diseases. Nat Neurosci. 13:805–811. 2010. View Article : Google Scholar : PubMed/NCBI
35	Chen K, Yang YH, Jiang SD and Jiang LS: Decreased activity of osteocyte autophagy with aging may contribute to the bone loss in senile population. Histochem Cell Biol. 142:285–295. 2014. View Article : Google Scholar : PubMed/NCBI
36	Stanfel MN, Shamieh LS, Kaeberlein M and Kennedy BK: The TOR pathway comes of age. Biochim Biophys Acta. 1790:1067–1074. 2009. View Article : Google Scholar : PubMed/NCBI
37	Sciarretta S, Volpe M and Sadoshima J: Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res. 114:549–564. 2014. View Article : Google Scholar : PubMed/NCBI
38	Mirzaei H and Longo VD: Acetyl-CoA synthetase is a conserved regulator of autophagy and life span. Cell Metab. 19:555–557. 2014. View Article : Google Scholar : PubMed/NCBI
39	Holstein JH, Klein M, Garcia P, et al: Rapamycin affects early fracture healing in mice. Br J Pharmacol. 154:1055–1062. 2008. View Article : Google Scholar : PubMed/NCBI
40	Wagner R, Mollison KW, Liu L, et al: Rapamycin analogs with reduced systemic exposure. Bioorg Med Chem Lett. 15:5340–5343. 2005. View Article : Google Scholar : PubMed/NCBI
41	Holstein JH, Klein M, Garcia P, Histing T, Culemann U, Pizanis A, Laschke MW, Scheuer C, Meier C, Schorr H, et al: Rapamycin affects early fracture healing in mice. Br J Pharmacol. 154:1055–1062. 2008. View Article : Google Scholar : PubMed/NCBI